Analysis of HIV-1 CRF_01 A/E Protease Inhibitor Resistance: Structural Determinants for Maintaining Sensitivity and Developing Resistance to Atazanavir

This publication has 37 references indexed in Scilit:

• Molecular Basis for Increased Susceptibility of Isolates with Atazanavir Resistance-Conferring Substitution I50L to Other Protease Inhibitors
  Antimicrobial Agents and Chemotherapy, 2005
• Sequence Variability of the HIV Type 1 Protease Gene in Thai Patients Experienced with Antiretroviral Therapy
  AIDS Research and Human Retroviruses, 2004
• Coot: model-building tools for molecular graphics
  Acta Crystallographica Section D-Biological Crystallography, 2004
• Comparing the Accumulation of Active- and Nonactive-Site Mutations in the HIV-1 Protease
  Biochemistry, 2004
• Identification of I50L as the Signature Atazanavir (ATV)–Resistance Mutation in Treatment‐Naive HIV‐1–Infected Patients Receiving ATV‐Containing Regimens
  The Journal of Infectious Diseases, 2004
• Multidrug Resistance to HIV-1 Protease Inhibition Requires Cooperative Coupling between Distal Mutations
  Biochemistry, 2003
• Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samples
  AIDS, 2003
• A Major Role for a Set of Non-Active Site Mutations in the Development of HIV-1 Protease Drug Resistance
  Biochemistry, 2003
• Protease sequences from HIV-1 group M subtypes A???H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide
  AIDS, 2000
• Structural and kinetic analysis of drug resistant mutants of HIV‐1 protease
  European Journal of Biochemistry, 1999